ProCE Banner Activity

Evaluating the Role of Immune Checkpoint Inhibitors in Unresectable Stage III NSCLC

Slideset Download
In this downloadable slideset, Ali McBride PharmD, MS, BCOP, FAzPA, explores the underlying rationale for immune checkpoint inhibitor therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

Expiration: April 26, 2019

No longer available for credit.

Share

Faculty

Ali McBride

Ali McBride, PharmD, MS, BCOP, FAzPA

Clinical Coordinator
Department of Pharmacy
The University of Arizona Cancer Center
Tucson, Arizona

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Ali McBride, PharmD, MS, BCOP, FAzPA

Clinical Coordinator
Department of Pharmacy
The University of Arizona Cancer Center
Tucson, Arizona